Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel two-component system found in Mycobacterium tuberculosis.

J Preben Morth1, Sylvi Gosmann, Elzbieta Nowak

  • 1European Molecular Biology Laboratory (EMBL) Hamburg, Notkestrasse 85, 22603 Hamburg, Germany.

FEBS Letters
|July 20, 2005
PubMed
Summary

Researchers discovered a new two-component system in Mycobacterium tuberculosis involving Rv3220c and PdtaR. This system regulates gene expression and offers potential targets for new tuberculosis therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct transport cycle and lipid regulation of a Mg<sup>2+</sup>-transporting P-type ATPase, MgtA.

Research square·2026
Same author

5'-Triphosphate guanosine RNAs recruit GTP-binding proteins to suppress RIG-I/IFN type I signaling.

Molecular cell·2026
Same author

Rational discovery of therapeutic PAK1 allosteric activators.

Cell·2026
Same author

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites.

Nature·2025
Same author

Rational design of antibodies with pH-dependent antigen-binding properties using structural insights from broadly neutralizing antibodies against α-neurotoxins.

mAbs·2025
Same author

From discovery to potential application: engineering a novel M23 peptidase to combat Listeria monocytogenes.

Scientific reports·2025

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Mycobacterium tuberculosis (Mtb) possesses complex regulatory networks essential for its survival and pathogenesis.
  • Two-component systems (TCS) are critical mediators of bacterial signal transduction, controlling adaptation to environmental changes.

Purpose of the Study:

  • To identify and characterize novel two-component systems in Mycobacterium tuberculosis.
  • To elucidate the biochemical mechanism and regulatory role of a newly discovered TCS.

Main Methods:

  • Biochemical assays including self-phosphorylation and phosphotransfer experiments.
  • Identification of protein-protein interactions and functional characterization of the TCS components.
  • Analysis of transcriptional antitermination activity.

Related Experiment Videos

Main Results:

  • Identification of a novel TCS comprising a histidine kinase (Rv3220c) and a response regulator (PdtaR).
  • Demonstration of Rv3220c autophosphorylation and subsequent phosphotransfer to PdtaR in a Mg2+/ATP-dependent manner.
  • The identified TCS functions at the level of transcriptional antitermination, regulating gene expression.

Conclusions:

  • A previously unknown two-component system has been characterized in Mycobacterium tuberculosis.
  • This TCS plays a role in transcriptional regulation via antitermination.
  • The phosphotransfer mechanism within this system presents a potential target for developing novel anti-tubercular therapeutic strategies.